Good day, ladies and gentlemen, and welcome to the General Electric First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen only mode. My name is John. I'll be your conference coordinator today. I'm sorry, sir, followed by 0 and a conference coordinator will be happy to assist you.
As a reminder, this conference is being recorded. I would now like to turn the program over to your host for today's conference, Pete Winoker, Vice President of Investor Relations. Please proceed.
Thanks, John. Good morning, all, and Apologies for the delay due to technical reasons. We had to switch to a backup line. It was choppy for a lot of investors and we wanted to make sure everyone could hear. I am joined today for our Q1 2021 earnings call by our Chairman and CEO, Larry Culp and CFO, Carolina Diebeck Happe.
Before we start, I'd like to remind you that the press release and presentation are available on our website. Note that some of the statements we're making are forward looking and are based on our best view of the world and our businesses as we see them today. As described in our SEC filings and on our Web Those elements can change as the world changes. With that, I'll hand the call over to Larry.
Steve, thanks and good morning all. Despite continued challenges in aviation and a still difficult comparison to last year, the Q1 marked a solid start to 2021. I'm confident this sets us up well to deliver on our 2021 commitments and profitable growth for the long term. Looking at the Q1 numbers on Slide 2. Orders were down 8% organically, primarily driven by Aviation Services and Power Equipment.
It was partially offset by continued strength in healthcare and renewables, as well as growth in power services. We're seeing better performance in our shorter cycle service businesses. Ex Aviation service orders were up 6% organically in the quarter. Our backlog stands at 830 $3,000,000,000 remains a strength with approximately 80% geared towards services where we have higher margins. Industrial revenue was down 10% organically.
Services continued to be a main focus as they were down 14%. While services may fluctuate quarter to quarter, especially as we've seen during the pandemic, we still expect growth in services this year. Ex Aviation, industrial revenue was up 1% organically. Adjusted industrial margin was 5.1%, Up 110 basis points organically. Notably, we saw organic expansion year over year with 3 of our 4 businesses improving as our cost actions 2020 continued to take hold.
Adjusted EPS was $0.03 with the majority of businesses improving offsetting Aviation. Carolina will provide more color shortly. Industrial free cash flow was a negative $845,000,000 Encouragingly, this was up $1,700,000,000 ex BioPharma, driven by better earnings and working capital. In all, we're seeing continued progress, especially on margins and cash flow, and we believe these improvements are sustainable. As we look to the Q2, we expect industrial free cash flow growth of similar magnitude to what we saw this quarter.
And despite ongoing volatility as the world fights through the pandemic, the guidance we provided a month ago remains changed. Turning to slide 3. There's a lot we're doing day in and day out to build momentum across GE. Jared, last month we agreed to combine GECAS with AerCap marking a significant catalyst in our journey to focus GE on its core 4 industrial businesses Power, Renewable Energy, Aviation, Healthcare and each business is critical to the global markets they serve. This transaction enables us to further strengthen the company for the long term, at closing bringing our total debt reduction to more than $70,000,000,000 over the last 3 years, while drastically simplifying GE in a number of ways, including our financial reporting.
All the while we've been fortifying GE's foundation. This starts first with our resilient and passionate team. They have been instrumental in driving our lean transformation forward and I'm grateful for their service. As we scale lean across the company, we're working to deliver safety, Quality, delivery and cost improvements as well as high quality growth. One recent example comes from digital services and renewables.
We heard from our customers that our cycle times and responsiveness needed improvement. A lean kaizen event revealed multiple An inconsistent process is in the way. Through value stream mapping, we developed standard work to decrease cycle time by 70%, enabling us to bid for and win more business. This has already led to more than $70,000,000 of backlog growth. Opportunities like these for high impact deployment of lean abound throughout our company.
We're coupling lean with significant decentralization effort. This means managing not just the 4 segments we report, but the nearly 30 businesses underneath them, where the work BE has done. This combination of lean and decentralization is maximizing value for our customers, While increasing accountability at the business level and even though it's still early in our journey, we're seeing tangible operational and financial results. For example, in a recent quarter, we have a strong quarter of our conversion to see how the strategy has come together, optimizing their operations through lead and redefining our market focus. This has led to double digit order growth in the quarter and 3 consecutive quarters of organic margin expansion.
This stronger foundation sets us up to spend more time playing offense. Our first priority is investment to drive organic growth efforts. We're improving our teams' ability to sell and service the products we have today and are generating our offerings with new product introductions. As you may have seen recently, we've had some changes in the portfolio. In Renewables, we were selected to move more than 530 turbines And Aviation, CFM secured lead engine and service agreements from Southwest Airlines and Scandinavian Airlines to Our MAX and 35 A320neo aircraft.
While at Healthcare, we've launched new ultrasound solutions, the B scan and Banyu, the industry's first AI offering for cardiac imaging. These innovations are supporting clinicians who need fast reliable insights at the point of care now more than ever. And while we're continuing to invest in technology and innovation to serve our customers and to lead our markets into the future, Fortifying our competitive position globally is of paramount importance. Over time, we will look to augment our organic efforts with inorganic investments that accelerate the implementation of our strategy and create real value for customers and investors alike. So as we think about what we're playing for, it is the LUM, building The GE Energy Technologies and expertise across critical markets enable us to lead along with our customers in creating a more sustainable future.
Our Renewables and Power businesses sit at the heart of the energy transition. Our opportunities were on full day during Earth Week. In Renewables, we've held the number one position in North America onshore wind 2 years running, and this is the fastest growing source of new power generation capacity. At Gas Power, we're playing a vital complementary role in decarbonizing at SAIL as we move from coal gas. In Healthcare, we're at the forefront of the Precision Health Revolution.
We have a leading position in many imaging modalities And we're growing our digital and AI capabilities, which will enhance the personalization of diagnostics and therapeutics. Take an area like cancer screening. Our solutions are improving patient outcomes, helping clinicians rule out false positives and streamlining workflows for providers And as we look to the future of flight, no business is better positioned than our Aviation business. In the near term, our focus is getting people back into the air today. And as the market recovers from COVID, we're well placed with the largest and youngest engine platform with more than 30,000 commercial engines and more than 60% of our fleet that has not yet had a second shop visit, underscoring the value our platform will generate for decades to come.
As we tackle the world's most complex challenges, we're also passionate about delivering for our customers across our vast global installed base. It's our services that keep us close to our customers day in, day out and create a significant source of recurring revenue. By staying true to our purpose and our customers, we'll unlock further upside potential in growth, profit and cash generation, leading to high single digit free cash flow margins over the next few years. Setting back, we're on a positive trajectory in 2021 and beyond. We're focused on delivering on our commitments and I'm confident that our continued efforts will build a stronger and more focused GE.
With that Carolina will provide further insights on the quarter.
Thanks, Larry. As you mentioned, our decentralization effort continues Now our financing is playing a critical role. We're developing and supporting a more granular operating view of our nearly 30 P and Ls And we're building lean scales to ensure the processes we're setting up are truly lean and automated. We're also deepening our focus on cash and strengthening our operational muscles. We're especially seeing this with billings and collections and we're really driving services growth, A key component of our team improved profitability.
For example, as we execute contracts, we're more focused on cost productivity and standard work. I'm confident this improved discipline will translate into improved results. Turning to Slide 4. Before we dive into the results, 2 items. First, With the announcement of AerCap and JAKAS combination, JAKAS has moved to discontinued operations.
As a result, we booked a day 1 loss on sale And our financials have been recast to reflect this transfer with depreciations suiting on the portfolio. Going forward, Any changes to earnings associated with GECAS in these COPs will primarily be driven by the AerCap stock price. 2nd, we're planning to transition our quarterly backlog disclosures to our remaining performance obligation basis or RPO starting in the second quarter. This change will simplify and streamline our reporting, further aligning our key metrics to those commonly used across our sector and reducing unnecessary extra work. Now, let me provide some color on the quarter on an organic basis.
Looking at the top line, recall that our businesses partially felt the impact of the pandemic in the Q1 of 2020. Aviation continues to be challenged managing through market volatility, which has weighed on our overall performance. Industrial revenue was down 10% this quarter, largely driven by services. However, ex Aviation revenue was up 1%, We saw increased demand as global procedure volumes recovered to pre pandemic levels. When power declined and renewables was roughly flat, This was largely driven by our increased focus on profitable growth.
Examples include reducing turnkey scope in gas power, Exiting new coal in power portfolio and increasing project selectivity in renewables. Next, industrial margins expanded 110 basis points with power, renewables and healthcare all contributing. Ex Aviation, margins expanded 4.50 basis points. A couple of standouts. 1, Gas Power Services with double digit revenue growth and significant margin expansion and this was supported by better performance in our transactional and sales and portfolios.
And 2, healthcare margin expansion. This was driven by better volume and cost productivity due to our lean efforts and expense management. We also continue to see sustainable benefits from our cost actions, including reduced headcount of roughly 23,000 year over year. We are on track to realize the incremental $1,000,000,000 of benefits in 2021. Finally, adjusted EPS was $0.03 in the quarter.
This reflects $0.04 of improvement year over year ex Biopharma, driven in roughly equal parts by industrial and capital performance. As we walk from continuing to adjusted EPS, we need to exclude the positive Baker Mark as well as the negative impact of significant higher cost restructuring programs and non operating expenses, primarily pension. Overall, we're encouraged by our industrial margin improvement. Moving to cash. Industrial free cash flow was negative $845,000,000 a use of cash and a decline from the 4th quarter, which we expect Consistent with what we shared earlier in the quarter, however, we saw significant progress across a number of our businesses with cash flow up $1,400,000,000 year over year and exBIO Pharma up $1,700,000,000 driven by earnings and working capital improvement.
Looking at earnings, they were down year over year on a reported basis. However, as I mentioned earlier, earnings were up Excluding the impact of Biopharma and Baker, with adjusted industrial organic profit up 18%. Moving to working capital. This was a use of $900,000,000 this quarter. We're seeing progress across the board with payables and inventories contributing the most of the improvement.
Looking at the flows within the quarter, receivables We're sourced from higher seasonal collections and daily management, but we also reduced short term factoring, which negatively impacted our free cash flow by 800,000,000 Our focus on stronger billings and collections continued with 2 days of DSO improvement. For example, in Aviation Services, Within our Series A portfolio, we were using value stream mapping and daily management and have improved billing timeliness by 15%. Inventory was a use of cash of $700,000,000 This was largely driven by renewables as expected to support second half volume. Inventory remains a key focus area for all leaders. Take our Healthcare business, where we're improving by half a turn year over year.
When I recently visited our team in Life Care Solutions, they showed me how the Hoisin County project Reduced inventory by more than 5% already this quarter, while delivering cost savings. We're continuously sharing these learnings across to inspire and accelerate further improvement. Tables for the use of $400,000,000 We saw seasonally lower volume in Power and Aviation. It was a significant improvement year over year. Progress was also a use of $400,000,000 as deliveries outpaced collection.
Contract assets was flat as deliveries offset collection. So working capital without the $800,000,000 impact of the factoring reduction Overall, a significant improvement. We're carefully optimizing our capital investments to drive long term growth. CapEx spend was up 18% sequentially, yet down 37% year over year. We've increased rigor in our investments and PDX capacity expansion in Healthcare.
In all, our efforts to improve working capital are taking hold And with additional opportunities near term, over time, sustainable free cash flow generation will mainly come from profitable organic growth combined with higher margins and longer term efficient capital deployment. Turning to liquidity and leverage on Slide 6. We've continued to solidify our financial position. This quarter, we reduced debt by approximately $4,000,000,000 Our liquidity is strong And we have ample additional liquidity sources for future deleveraging actions. This includes proceeds from the GECAS transaction, positive cash flow and monetizing our remaining stakes in Baker and AerCap.
Post transaction close, we expect to reduce debt significantly, bringing our total reduction to $70,000,000,000 since the end of 2018. Additionally, we do not anticipate any further funding requirement for the GE pension plan in the foreseeable future. And by that, I mean the end of the decade. This is due to our $2,500,000,000 pre funding in 2020, our investment portfolio performance, as well as the recently enacted American Rescue Plan Act. Since the beginning of 2019, we've been balanced by $8,000,000,000 bringing it to about $6,000,000,000 at quarter end.
Effective April 1, we discontinued the majority of our factoring programs. As I talked about that outlook, We'll exclude the related cash flow impact going forward, which we expect to be between $3,500,000,000 $4,000,000,000 of this will be felt in the 2nd quarter. Combining this with $3,500,000,000 to $4,000,000,000 with the $800,000,000,000 reported cash impact in the quarter from the normal course activity gets you to the $4,000,000,000 to $5,000,000,000 range of cash that we described last month. If you apply the same logic and cancel out the factoring effect from our discontinued programs in 2020, after rebaselining for biopharma and The net free cash flow range of $2,400,000,000 excludes the impact of the negative $8,000,000 factoring in the Q1. Excluding the full year impact factoring, the majority of our cash flow improvement in 2021 from earnings To reduce our reliance on factoring, we will continue to focus further improvement on our core billings and collections capabilities, leading to better cash performance over time and there is no change to our view from outlook where the improvement is driven by our underlying operating performance.
Due to us reducing restructuring as well as better managing working capital and cash, our cash needs have decreased Moving to our business results, on an organic basis. Power. Our Gas Power and Power portfolio teams continue to make progress. We're especially encouraged by the growth in Gas Power Services. Overall, Power remains on track to deliver their financial commitments for the year.
Looking at the market, global electricity demand grew 3% this quarter, Driving GE Gas Turbine Utilization and High Single Digits. Corporate sales declined 20% in the quarter. At Gas Power, equipment revenues were down 50%, driven by the non repeat of a large turnkey order. However, We booked 18 turbines, up 9. Service orders were up 11% with strong strong growth.
This was driven by higher synergies and stronger commercial performance due to the pandemic related actions last year. Our power portfolios were down 7% as we expected, driven by our planned exit of new built coal business. This was partially offset by double digit growth at Power Conversion. Backlog of $78,000,000,000 decreased year over year, largely driven by timing of Revenue was down. Power was down 2%.
This was driven by equipment, down 25%. We had significantly lower turnkey slow project as anticipated, while at the same time, we shipped more heavy gas turbines this quarter, up 6. And we commissioned 3.6 gigawatts of power to the grid, including 3 units. As you heard from Scott at outlook, we've been more selective on turnkey projects and we're transitioning to more equipment projects. It is better risk return equation over time.
We saw meaningful improvement in services revenue and Due to strong transactional backlog execution outages, power portfolio revenue was down 9%, driven by spin. Offsetting this, Power Conversion and Nuclear were both up. Segment was negative, but improving by 110 basis points. Gas Power margin was positive and expanded significantly. This was largely driven by positive mix from higher margin services volume and reducing fixed costs.
Our portfolio margin contracted, project execution and unfavorable legacy project arbitration resolutions. We're progressing through our planned exit of newbuild coal and concluded our European Works Council consultation this quarter. Both Power Conversion and Nuclear expanded margins and operational improvements continued. Turning to Renewables, We continue to improve operational execution and scale of our business and we remain on track for our full year commitment. Starting with the market.
In onshore wind, we expect the U. S. Market to slightly decrease this year, while robust growth continues to blow us. In offshore wind, the strong market trends are expected to continue through the decade. And broadly speaking, Grid is positioned to gain momentum as the energy transition accelerates and government stimulus increases.
Now on the quarter. Orders grew double digits in onshore, offshore and grid solutions all up. Grid was the biggest driver followed by a large HVDC system order. Onshore wind services, including more than 120 repower units increased significantly. Offshore wind is building momentum with more Haliadex orders expected in the second half.
Revenue was flat with equipment revenues growth up high single digits offset by a significant decline in services. In onshore wind, equipment was higher with more than 7 60 units delivered. Mobile services were down as we did not deliver any repower upgrades. However, digital services were up significantly excluding RePower. Offshore wind growth was driven by continued execution on EDF's 6 Megawatt PPG project in France.
Grid declined due to digital activity and commercial execution. Segment margin, while negative, improved by 3 10 basis points. In Onshore Wind, margin grew significantly, driven by cost productivity and Next on Aviation. Our team continues to position the business for the rebound despite current market challenges. As the aviation end market recovers, which we believe will begin in the second half, we expect to deliver on our 'twenty one outlook, Revenue growth, margin expansion and better cash generation, down 40% year over year, in line with our guidance and outlook.
We're encouraged that March departure levels improved significantly versus January February, But regional pressures continue, especially in Europe and Asia ex China. Orders were down more than 25% With commercial services down more than 40%, but some improvement sequentially and commercial engines down less than 10%, supported by multiple large orders, including one for 22 GE9X engines. Deviation backlog At about $260,000,000,000 down slightly sequentially, the largest drivers for commercial engines and services with approximately 400 LEAP-1B cancellations. For context, our LEAP unit backlog stands at more than 9,200 engines. The revenue decline was driven by Commercial Engines, down double digits and Commercial Services down 40%.
Commercial services saw lower spare parts sales and lower spare parts. Although dynamics varied by engine and region, shop This is where broadly in line with our guided outlook. In military, revenue was flat due to favorable equipment mix despite 50 lower unit shipments. Overall, engine deliveries remain pressured, primarily in rotorcraft, and our team continues to address the supply chain challenges. Segment margin contracted to approximately 13%, primarily driven by Commercial Services.
However, The incrementals improved to 19% and margin expanded sequentially as our cost actions continue to take hold. Moving to Healthcare. We're excited about the progress we're seeing. The team's strong performance shows how implementing lean and decentralization It's giving real results. Overall, our market fundamentals are also improving.
For the 3rd consecutive quarter, Global procedures volumes were up double digits. Demand for non pandemic products was solid as government stimulus drove strong order growth in China, India and Japan. Meanwhile, demand for pandemic related products began to normalize. We're seeing elective procedures return to pandemic levels, But there is still much for us to do to support our customers. Many are running at reduced capacity and have patients waiting longer than usual for screenings, treatments and procedures.
With that backdrop, health care orders continue to improve. Healthcare system orders were up 5% with the equipment and services growth. Imaging and ultrasound improved double digits And compared to the Q1 2019, ANSUTI grew across all regions, while Life Solution orders were down As pandemic related demand softened, PDX demand continued to recover with orders up 7%, driven by CT screening for cardiac disease Healthcare Systems, up 7% across businesses. Two highlights. Ultrasound demand was high With growth across most regions and all product lines and Life Care Solutions grew again this quarter.
CDX revenue declined driven by profitability and continued cost reduction, while we still invest growth, especially in imaging, ultrasound and LCS. Moving to Slide 8. At Capital, operations generated a net loss of half of the net loss. This was primarily driven by insurance and tax, partially offset by lower EFS gains. At insurance, we continue to see a positive claims trend strong investments versus last year when we had pandemic related marks and impairments as well.
GE Capital assets excluding cash down almost $6,000,000,000 sequentially, driven by the JCAF transaction and our factoring. Within this continued two points, So, Jacobs had a net loss of $2,600,000,000 which includes the loss on sale of $8,000,000,000 from the AerCap transaction, offset by about $200,000,000 of earnings. With the collections progress, we ended the quarter with 20 aircraft on ground. We may see levels fluctuate throughout 2021 due to the continued market volatility. We've previously noted ongoing litigation related to our runoff for the full year.
This quarter, we recorded charges of approximately $300,000,000 This is based on the rising number of borrower lawsuits filed and expected to be filed in the future as well as higher discount rates. We expect upcoming decisions of the European Court of Justice and The Polish Supreme Court to have an impact on the litigation landscape for Polish banks, including our run off Polish mortgage business. Moving to corporate. We remain focused on linear processes and decentralization. If I compare the adjusted corporate costs With when I started a year ago, we are down almost 50%.
Most notably here are our functional costs and operations, which improved over 40% and Digital focusing on driving growth and improved profitability with a strong performance from Grid Software this Taking a step back, Larry and I recognize the positive, sustainable impact that Loon will create at GE. We are picking up the pace. And while it's still early, we're building momentum with measurable impact this quarter, as you've seen. This is becoming more visible at corporate as well. We've significantly transformed how we operate, moving more work to the businesses and further streamlining the remaining corporate functions.
And we have an increased focus on strategy, capital allocation, research, and Governance. Now Larry, back to you.
Carolina, thanks. Let's go to slide 9. In summary, this quarter was a solid start to 2021. Thanks to our team, we're making measurable and sustainable progress throughout the organization. The GECAS transaction announced last month marks an important step forward in making GEA more focused, Simpler and stronger industrial company, one that's even better positioned to serve the needs of our customers and the world with leading technologies and strong service capabilities across our installed base.
As we are building a world that works, we're also creating a more sustainable future, Leading in the energy transition, driving more integrated and personalized health care and enabling smarter and more efficient flight. These examples we've shared today helped convey the real operational and cultural changes underway at GE. There are many steps, big and small, happening across our company right now that make me excited about the future. We remain focused on growth, profit and cash generation, and I'm confident in our ability to drive value for the long term. Steve, with that, let's go to questions.
Thanks, Larry. And before we open the line, I'd ask everyone in the queue to consider your fellow analysts again John, can you please open the line?
Yes. And our first question is from Markus Mitterbier from UBS.
Yes. Hi, good morning, Larry, Carolina and Steve.
Good morning. Good morning.
Maybe I'll start with the bigger picture question, Hilary. So you talked more and more about playing offense And playing for the long term here. If I bring this back to free cash flow, I know that you kind of guide to 2023 at high single digit Free cash flow margins, but you removed a lot of headwinds. Carolina mentioned that the pension headwind is gone potentially now to the end of the decade. The factoring headwind, I think even if we look at just the near term here, the $4,000,000 to $5,000,000 guide that we all reflected, I think The near to impact is probably $800,000,000 less, so the fact that I think you kind of implicitly increased your cash Hello guys today, unless I'm misinterpreting that.
But if I take it more to the long term, right, and I look at sort of these removed headwinds And peers in a lot of your business being significantly above that high single digit free cash flow margin, How do you think about the portfolio and that target in the long term?
Marcus, a couple of comments there. Let me just Level set, I think what we're trying to do today is reiterate that what we said about a month ago or so At the GECAS announcement with respect to our outlook for this year in terms of free cash potential, the 2.5% to 4.5%, that's back, Right. So no intention to change that. As Carolina highlighted, we did have $800,000,000 of factoring discontinuation pressure in the Q1 that we're not adjusting for, but we do want to flag it for you because it's akin to what we will adjust for more formally the rest of the year now that we have formally discontinued the factoring program. But I think that as you ask about the longer term, there's no question that We feel confident today about our potential to deliver on that high single digit free cash flow Margin in 2023 or hopefully shortly thereafter, right?
And we're really talking about You take the midpoint of that, call it 8% on, let's say, the 2019 revenue base, Somewhere in the $85,000,000,000 to $90,000,000,000 range that gets us to a $7,000,000,000 free cash number. I think given the way we are running the businesses Better today, at least compared to what I saw when I walked in 2.5 years ago, the opportunities I think we have clearly framed in front of us around the energy transition, around Precision Health, around the future of flight. And as you highlight, as Carolina noted, A number of headwinds will dissipate over time, be it some of the restructuring in Power, Be it pension, I mean, what terrific news that is for us in addition to the interest step down and the like. So there's a lot of things We're working on that we're encouraged by. There are a number of things that are going to dissipate over time.
And you put all that together, while we've got Plenty of work to do. So there's no declaration of victory here. I think we're just trying to underscore our continued confidence that we can deliver on those numbers over Clearly, we need aviation to come back. I think we're encouraged by a number of the signs there. So that's encouraging, but certainly other parts of the world as you well know are still fighting this horrible pandemic That creates a little bit of the volatility that we referred to.
But all in, we continue to believe the Aviation recovery is more a matter of when, not if. And again, with that 37,000 strong narrow body fleet out there, the youngest in the industry, we think we're well positioned to serve And to deliver results for our investors as that occurs.
Our next question is from Julian Mitchell from Barclays.
Hi, good morning. Just wanted to try and clarify that Q2 industrially cash flow comment. So is the point that when you're talking about the year on year improvement, we should expect of that, I suppose, dollars 2,100,000,000 base, We should be thinking about a sort of $1,700,000,000 increase ex biopharma. I just wanted to make sure which sort of comparison point we're And also maybe I like to that, any comments around how
Okay. So let me start with the question on the 2nd quarter free cash flow. So What I mentioned was that we saw the improvement year over year, to your point there, of 1.7, excluding biopharma or free cash flow. We do expect to see similar improvement in the Q2. So that's the right way to look at it.
Julien, good morning. With respect to Aviation, you're right. The 12.8% op margin Brent in the quarter It's good all things considered, but organically down 200 basis points from where we were a year ago. I think the top line was softer than we had anticipated, primarily functions of services getting off to a slightly slower start. And frankly, we continue to be challenging.
I mentioned this in our prepared remarks on the military side of the house just in terms of deliveries. We have some past due backlog there that we need to clear, which will be helpful as well. So as we go through the year, I think you'll see the cost efforts from last year play out. Clearly, the comps get easier. And as we get a better mix of business with services coming back, We clear those issues in the military side of the business.
I think you should continue to see us improve the margins from here. But again, we really need that overall market recovery to play out as We believe it will largely in the second half beginning of the second half. Thank you.
Our next question is Steve Tusa from JPMorgan.
Hey guys, good morning.
Good morning, Steve. Good morning.
So just to follow-up on Julian's question, can you just give us The base of what the factoring actually was last year in the Q1 and the second quarter on an absolute basis. And then for the year, so are we is the $800,000,000 you did in the Q1 plus the 3.5 4 in the second, is that how you get to the 4 to 5? Or is a part of the 4 to 5 still to come after second quarter? It's just It's a big I think an 8 ks with all this would be helpful, but just if you could be specific about the Q1 impact, dilute impact in 2020 and the 2nd quarter absolute impact in 2020, so we can kind of figure out what the basis is.
Good morning, Steve. So maybe let us go back to outlook. So at outlook, we said that we would Basically, discontinued the majority of our factoring programs, right? And we talked about that the impact of that would be $5,000,000,000 to $5,000,000,000 on our Cash flow, right? So what is the $800,000,000 of reduction in the quarter, that's still in our numbers Because it's before we technically discontinued, right?
So you have that €800,000,000 and we expect 2Q through 4Q to be 3.5 $4,000,000,000 the majority of that in the second quarter. If you take that together, you get $4,300,000,000 to $4,800,000,000 for the full year And that's then in line with the 4% to 5% that we shared at outlook.
And what is the year over year impact Of these because we're talking about absolute free cash flow impact versus year over year impact. Sometimes, I don't know, people talk about the impact being year over year versus absolute. What is kind of the year over year impact?
Exactly. And that's also why when we're talking about it, we talked about the impact in 2021, but that's also why we're helping you to rebalance 2020 Reduced sort of from the factoring noise. And if you do that, we talked that outlook about 2020 starting with $600,000,000 you rebase that for We talked about the COVID and we talked about biopharma to 0. If you then take out the equivalent, you get a Positive free cash flow of $2,400,000,000 for 2020. And your question specifically on the Q1, In the Q1 in 2021, you obviously have the headwind of 800 that you saw in our numbers here that you then mentally adjust for.
And then The equivalent of last year's reduction of those programs is about $1,000,000,000 right? So if you do the comparison there, those are the numbers for the Q1.
Our next question is from Andrew Obin from Bank of America.
Yes. And just not to talk too much about factoring, but $1,700,000,000 improvement you expect So just can you walk us through how much of it is factoring drag going away and how much of the year over year improvement It is earnings driven versus other working capital improvement. And if you could just give us directionally color by segment As to what drives the year over year improvement, that would be great as well. Thank you.
Hi, Andrew. So if we start with the improvement for 2nd quarter, we are saying is that we expect the improvement to be roughly in line to the improvement that you saw in the Q1, and that's on the reported basis, right? When it comes to the composition of that, we expect a healthy part of that to be profit improvement, But also working capital improvement.
Our next question is from Jeffrey Sprague from Vertical Research
partnered. Thank you. Good morning.
Good morning, Joe.
Good morning, Joe. Good morning, all. Yes, let me just kind of Looking at kind of historical patterns, maybe just a little color on what the big variances are in the back half, right? I know you're going to have 787 ADAs and progress payments moving around, what are the really big kind of swing factors or cushion items That maybe define the lower end of that range for the year.
Yes.
Let me take that here at the outset. I'm not sure I would buy into your premise That we've got the visibility that you're suggesting that we do. I think the range that we have today, in line obviously with the range we've shared since early in the year, Captures what we know and what we don't know. Clearly, we're waiting for Aviation to begin to snap back. That is an important swing factor for us.
I think we've been consistent talking about that. I don't think there's much of a historical precedent In that business, given the way the pandemic is ravaging various parts of the world and in turn both leisure and business travel, Clearly, we have a new administration that's doing a lot of good things medium to long term here to help In onshore and offshore, and we as our customers do need to have, I think, better visibility With respect to number of funding programs, tax policy changes and regulatory approvals, It will have a real impact on orders and in term down payments in that business. So I don't want to Lay out a long list, but there are a number of moving pieces here. And given the nature of our business, as you well know, The number of orders are often large and they carry with them significant cash impacts may happen So I think what we're going to do going forward is what we've done here in the last several years, tell you what we know, tell you what we don't. I think we're mindful that the factoring dynamic creates some noise here.
But as we've said a couple of times, No change to the effect, 4% to 5% as we discontinue the factoring programs. And operationally, we feel good about the 2.5% to 4.5%. If we can get to the high end of that range, Great. If we can do better, we will. But it's a long term game here and that's the way we're going to play it out.
Our next question is from Nigel from Wolfe Research.
Let's come back to Nigel then, John.
Our next question is from Deane Dray from RBC Capital Markets.
Thank you. Good morning, everyone.
Good morning, Dean.
Hey, there's a lot of angst right now across the industrials about Cost inflation, supply chain disruptions, I did see in the appendix on military aviation I saw some supply chain pressures, but just broadly, where are the pinch points? Is it Would it represent a potential win for the Q2 or for the balance of the year? Any update there would be helpful. Thanks.
Sure. Dean, you touched on a couple of different things. Let me try to take from a price cost perspective, A number of moving pieces. We're clearly seeing some price pressure Not unlike what you've heard about elsewhere, OpEx, resins, certain metals, but I think we've also been able To mitigate that in the quarter to effectively a wash number of things that we did of course from a cost Management perspective, let alone going after the price where we I think where we're seeing supply issues, Particularly where we're seeing a little bit better growth interestingly enough, not surprisingly, Healthcare probably being number 1, Renewables being the other, Again, chips, resins and the like. I think right now it's more isolated.
Call it a nuisance would be maybe An understatement, but I think we're working through that and presumably have that captured In the guide that we're reiterating today, with respect to military, that's a little bit of a different challenge, right? That's not a price cost play. That's not a supply chain disruption issue given the snapback. There are a number of things that we need to do a better job of inside of our own facilities. We need help from our supply base there, So that we've got a smoother, more consistent flow into and out of into, through and out of The manufacturing processes, so we're working on that.
That's not going to be something that we declared victory on here in the Q2. But rest assured, we're spending a lot of time Working those issues with our customers in mind, 1st and foremost.
So hopefully, that gives you a little bit
of a color for What's happening operationally? These are the challenges when you get an economic recovery and we're glad to see these
Our next question is from Nigel Coe from Wolfe Research.
Hi, good morning. Can you hear me?
We can.
Clearly, nice. Good morning. Good.
That's good news. I'm not sure what happened there. Thanks again. So I want to ask a question on insurance. Obviously, GECAS goes a long way to sort of making the balance sheet a lot simpler.
Insurance seems to be the next logical step. And I'm wondering if some of the improvements we're seeing in claim experience, obviously, more equity buffer there, Rising rates, whether that means that insurance is even close to being on the table at this point?
Nigel, I would say that a number of those trends clearly are encouraging and helpful here in the very near term. I'm not sure that we're quite ready today to suggest that, all of that means that We could do something along the strategic dimension with insurance. I think we will continue to Manage premium, I think we'll manage claims, let alone the investment portfolio As thoughtfully as we can as long as that runoff liability is in our hands, but I do think that Given that the curves have more or less played out as we remodeled them a few years back, clearly you've got the COVID-nineteen, GE is in a very different place today. I'm optimistic that we'll continue to explore Strategic options in and around insurance, and we'll see what happens. I don't want anyone to bank on that as a dead cert.
By the same token, I think what you've heard us say for some time is we're very keen To focus on our core 4 industrial businesses, insurance is not inside that perimeter. So if and when we have an opportunity to do something smart, creative and strategic around insurance, rest assured we'll give that our full attention.
And our next question is from Jack Pokrzywinski from Morgan Stanley.
Hey, good morning, guys.
Good morning, Josh. Good morning.
Just Larry, going back to
a comment I on outlook about shop visits in aviation and maybe not using that as a single point metric, That scope is also an important factor. Just given that your comment earlier that aviation is kind of an important swing factor in the second half, How are you seeing that scope or kind of dollar per shop visit evolve? Is that trending within your expectations? And Any trend line there that we can point to that say that things are getting sort of better or worse as the world unfreezes?
Well, I think the expectation, Josh, is that things will get better In terms of not only, if you will, volume of shop visits, but scope or the value of a shop visit. That said, There are different types of shop visits, right? Some of which we perform, some of which we don't. I think we've got better visibility clearly when we're doing all the work. I think that is playing out as we would have anticipated.
You well know a number of cross currents and pressures there In the short term, as airlines battle COVID, we've got less visibility On the channel side of things, and I think we clearly see signs that over the last several quarters, A number of our partners have brought inventory levels down. That doesn't necessarily mean a scope reduction on the part of the shop visit being performed, But it does have a knock on effect relative to the value for us in the very near term. But like any The lift off that base and that is part of what I think we will see. That's part of what we are assuming we will see as we see the snapback in shop visits going forward. But that all needs to play out.
Again, a number of encouraging signs in certain markets, the U. S. And China first amongst them, But clearly, some signs in places like India, like the rest of Asia Pac, parts of Europe That are of concern and need to stabilize before they improve.
Our next question comes from Andy Kaplowitz from Citigroup.
Good morning, guys.
Good morning. Good morning, Andy. Good
morning, Andy.
Larry, could you give us a little more color into how you're thinking about execution in health I know you said in your outlook call that you're only going to increase healthcare margin for the year by 25 basis points to 75 basis points. But As you said, it's up 2 70 basis points organically. So did you, for instance, not increase R and D yet as much as you thought? Are you And I know it's early, maybe you're a bit worried about supply chain, but could that margin forecast that you have in healthcare end up being quite conservative?
Andy, I would say that credit to the team, we have really 3 quarters here running where despite a choppy somewhat unpredictable top line given the pandemic, They've done a heck of a job on margins and cash, right? And I just think that is a function of a lot of the lean work we've talked about. That's probably our operating segment where we have pushed decentralization the furthest to date. I do think we're seeing some early results there. There's no question that they've gotten off to a good start, right?
Order is up 5%. Let's remember though, it's a bit of a Dickens dynamic, right? Two cities, pandemic related products, Well off where we were a year ago, but the core imaging and ultrasound franchises from an orders perspective are up over 20% year on year in the first That gives you a little bit of a sense of the play there and that's really where Precision Health happens. With due respect, it's not ventilators and patient monitors. They have a role to play, but it really is in and around ET ultrasound and the core imaging product.
I think as we go forward, while we're encouraged by the 2 70 bps, if we are getting a market Snap back, more than we would have anticipated. And if we see that being sustainable in addition to the operating improvements we're going to make, I think what you'll see us do Andy is frankly try to temper the margin expansion this year And look to put more money back into the business. In no way does that suggest we have not been funding those opportunities that we have wanted to, but you have to follow Really the history of the last couple of years, right? We were prepping for an IPO. We pulled that off.
Sold BioPharma, that's a distraction. Getting back to basics Headlong into a pandemic, we're really I think getting into calmer water in Healthcare, which gives us an opportunity now that I think we're proving we can deliver on margins in Cash to drive growth, put more money into it, but make sure those are good investments, be it in sales force additions, be it in digital, be it in new products, Right. So we're not going to call that today, but don't be surprised if we continue to see good top and bottom line performance That we call off some of the outsized margin improvements, so that we're putting that back into the business and have a good 2021, But also a good 2022, a good 2023 in a business that I think more people are going to appreciate as a real value driver for GE going forward.
John, we're late at this point. Why don't we take one last question and then we'll call it and follow-up with everybody else offline.
And we have from Pat Davis from Amelius Research.
Hey, good morning, everybody. Thanks for fitting me in. Good morning, Scott. Good morning, Scott. You guys talk a lot about lean, you talk about the turnaround, talk a little bit less about price.
How and I guess it's different in every business, I'm sure, but how are you going about changing kind of the historic bidding process? And how big of a importance, I mean, I know you did mention price a few questions ago, but how important is price to particularly net price to the turnaround and things like renewables.
Well, I In Renewables, Scott, if we just focus there, when we talk about selectivity, That really is about price and margins, but also about terms and conditions, which I think of is really, if you will, Risk that isn't necessarily modeled, but can come back and course through and wreck the P and L if we're not careful. So a good bit of what you see happening in onshore wind and I think increasingly in grid It is a little less of an aggressive pursuit of the top line with more of a balanced approach To go after the business where we're well positioned, where we can serve and make a little bit of money, hopefully a little bit more money over time, But also have a less have a better risk profile, right, to make sure that We're in the geographies, we're in the applications where we have higher confidence. So it's not priced the way it is in healthcare obviously. But if you go through Our deal review process, I think you would see that selectivity in those two areas in Renewables and it's very much the same process we are driving across the organization. Now there are plenty of things that we'll do in the short term price where we can, surcharges.
A number of our long term contracts across the company have inflation based escalators in them, which helps us and in environments like the one we may see play out here in the next couple of years. But we're really just again trying to Pursue the quality business across the portfolio where we can serve the customer well and do that in a way that drives Margins and cash for our investors.
John, I think we're going to have to call it at that point. To everybody, I want to thank you for your patience at the beginning of the call. My team and I stand ready to help clarify your questions. I know there's some complexity that people are trying to work through on the factoring, which we've tried to clarify, but we're available to help really get it down and fine tune it for everybody. Okay.
So look forward to speaking to you and have a great day.
Thank you, ladies and gentlemen. That concludes today's call. Thank you for participating and you may now disconnect.